Sarcopenia is not a prognostic factor of outcome in patients with cervical cancer undergoing concurrent chemoradiotherapy or radiotherapy

Hirofumi Matsuoka, Keiichiro Nakamura, Yuko Matsubara, Naoyuki Ida, Takeshi Nishida, Chikako Ogawa, Kuniaki Katsi, Susumu Kanazawa, Hisashi Masuyama

Research output: Contribution to journalArticle

Abstract

Background/Aim: The objective of this study was to determine if sarcopenia was a predictor of poor prognosis in patients with cervical cancer (CC) undergoing concurrent chemoradiation therapy (CCRT) or radiation therapy (RT). Materials and Methods: A total of 236 patients with CC undergoing CCRT or RT were retrospectively examined. We determined if clinical characteristics and survival were correlated with pretreatment sarcopenia, measured as psoas muscle index (PI) or skeletal muscle index (SMI). Results: Pretreatment PI and SMI were related to parametrial involvement with CC undergoing CCRT or RT (p=0.002, and, p=0.034, respectively). The median progression-free survival (PFS) and overall survival (OS) times in patients undergoing CCRT or RT were 29.0 and 34.5 months, respectively. Neither PI nor SMI were prognostic predictors in patients with CC undergoing CCRT or RT. Conclusion: Sarcopenia is not a predictive factor of outcome in patients with CC undergoing CCRT or RT.

Original languageEnglish
Pages (from-to)933-939
Number of pages7
JournalAnticancer Research
Volume39
Issue number2
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Sarcopenia
Chemoradiotherapy
Uterine Cervical Neoplasms
Radiotherapy
Psoas Muscles
Skeletal Muscle
Therapeutics
Survival
Disease-Free Survival

Keywords

  • Cervical cancer
  • Concurrent chemoradiotherapy
  • Predictor of poor prognosis
  • Sarcopenia

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Sarcopenia is not a prognostic factor of outcome in patients with cervical cancer undergoing concurrent chemoradiotherapy or radiotherapy. / Matsuoka, Hirofumi; Nakamura, Keiichiro; Matsubara, Yuko; Ida, Naoyuki; Nishida, Takeshi; Ogawa, Chikako; Katsi, Kuniaki; Kanazawa, Susumu; Masuyama, Hisashi.

In: Anticancer Research, Vol. 39, No. 2, 01.02.2019, p. 933-939.

Research output: Contribution to journalArticle

@article{04060e45ffdf4f7ba939e64c47cf12ff,
title = "Sarcopenia is not a prognostic factor of outcome in patients with cervical cancer undergoing concurrent chemoradiotherapy or radiotherapy",
abstract = "Background/Aim: The objective of this study was to determine if sarcopenia was a predictor of poor prognosis in patients with cervical cancer (CC) undergoing concurrent chemoradiation therapy (CCRT) or radiation therapy (RT). Materials and Methods: A total of 236 patients with CC undergoing CCRT or RT were retrospectively examined. We determined if clinical characteristics and survival were correlated with pretreatment sarcopenia, measured as psoas muscle index (PI) or skeletal muscle index (SMI). Results: Pretreatment PI and SMI were related to parametrial involvement with CC undergoing CCRT or RT (p=0.002, and, p=0.034, respectively). The median progression-free survival (PFS) and overall survival (OS) times in patients undergoing CCRT or RT were 29.0 and 34.5 months, respectively. Neither PI nor SMI were prognostic predictors in patients with CC undergoing CCRT or RT. Conclusion: Sarcopenia is not a predictive factor of outcome in patients with CC undergoing CCRT or RT.",
keywords = "Cervical cancer, Concurrent chemoradiotherapy, Predictor of poor prognosis, Sarcopenia",
author = "Hirofumi Matsuoka and Keiichiro Nakamura and Yuko Matsubara and Naoyuki Ida and Takeshi Nishida and Chikako Ogawa and Kuniaki Katsi and Susumu Kanazawa and Hisashi Masuyama",
year = "2019",
month = "2",
day = "1",
doi = "10.21873/anticanres.13196",
language = "English",
volume = "39",
pages = "933--939",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Sarcopenia is not a prognostic factor of outcome in patients with cervical cancer undergoing concurrent chemoradiotherapy or radiotherapy

AU - Matsuoka, Hirofumi

AU - Nakamura, Keiichiro

AU - Matsubara, Yuko

AU - Ida, Naoyuki

AU - Nishida, Takeshi

AU - Ogawa, Chikako

AU - Katsi, Kuniaki

AU - Kanazawa, Susumu

AU - Masuyama, Hisashi

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Background/Aim: The objective of this study was to determine if sarcopenia was a predictor of poor prognosis in patients with cervical cancer (CC) undergoing concurrent chemoradiation therapy (CCRT) or radiation therapy (RT). Materials and Methods: A total of 236 patients with CC undergoing CCRT or RT were retrospectively examined. We determined if clinical characteristics and survival were correlated with pretreatment sarcopenia, measured as psoas muscle index (PI) or skeletal muscle index (SMI). Results: Pretreatment PI and SMI were related to parametrial involvement with CC undergoing CCRT or RT (p=0.002, and, p=0.034, respectively). The median progression-free survival (PFS) and overall survival (OS) times in patients undergoing CCRT or RT were 29.0 and 34.5 months, respectively. Neither PI nor SMI were prognostic predictors in patients with CC undergoing CCRT or RT. Conclusion: Sarcopenia is not a predictive factor of outcome in patients with CC undergoing CCRT or RT.

AB - Background/Aim: The objective of this study was to determine if sarcopenia was a predictor of poor prognosis in patients with cervical cancer (CC) undergoing concurrent chemoradiation therapy (CCRT) or radiation therapy (RT). Materials and Methods: A total of 236 patients with CC undergoing CCRT or RT were retrospectively examined. We determined if clinical characteristics and survival were correlated with pretreatment sarcopenia, measured as psoas muscle index (PI) or skeletal muscle index (SMI). Results: Pretreatment PI and SMI were related to parametrial involvement with CC undergoing CCRT or RT (p=0.002, and, p=0.034, respectively). The median progression-free survival (PFS) and overall survival (OS) times in patients undergoing CCRT or RT were 29.0 and 34.5 months, respectively. Neither PI nor SMI were prognostic predictors in patients with CC undergoing CCRT or RT. Conclusion: Sarcopenia is not a predictive factor of outcome in patients with CC undergoing CCRT or RT.

KW - Cervical cancer

KW - Concurrent chemoradiotherapy

KW - Predictor of poor prognosis

KW - Sarcopenia

UR - http://www.scopus.com/inward/record.url?scp=85060999194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060999194&partnerID=8YFLogxK

U2 - 10.21873/anticanres.13196

DO - 10.21873/anticanres.13196

M3 - Article

C2 - 30711978

AN - SCOPUS:85060999194

VL - 39

SP - 933

EP - 939

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2

ER -